Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0000950170-24-073371

Chief Technical Officer acquired 31,250 shares (grant or award)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Otero Jose Manuel Chief Technical Officer 2024-06-12 Grant or award 10b5-1 +31,250 31,250 D
Derivatives
Otero Jose Manuel Chief Technical Officer 2024-06-12 Grant or award · Stock Option (Right to Buy) 10b5-1 +187,500 187,500 D
Loading xslF345X05/ownership.xml…